Hepatitis

Worldwide, approximately 170 million people are chronically infected with hepatitis C virus (HCV) and another 350 million individuals are chronically infected with hepatitis B virus (HBV) (1,2). Canada is estimated to have 240,000 to 300,000 HCV and 200,000 to 280,000 HBV chronic carriers (3,4). Wit...

Full description

Bibliographic Details
Published in:	Canadian Journal of Infectious Diseases
Main Author:	Mel Krajden
Format:	Article
Language:	English
Published:	Wiley 2001-01-01
Online Access:	http://dx.doi.org/10.1155/2001/428059

Similar Items

The Laboratory Diagnosis of Hepatitis B Virus
by: Mel Krajden, et al.
Published: (2005-01-01)

Practical Approach to Issues in Virology
by: Mel Krajden
Published: (1996-01-01)

Capacity Enhancement of Hepatitis C Virus Treatment through Integrated, Community-Based Care
by: Warren D Hill, et al.
Published: (2008-01-01)

Health Care Costs Associated with Hepatitis C: A Longitudinal Cohort Study
by: Mel Krajden, et al.
Published: (2010-01-01)

Factors Associated with Spontaneous Clearance of Hepatitis C Virus among Illicit Drug Users
by: Jason Grebely, et al.
Published: (2007-01-01)

Front-line staff-led integrated care
by: Gail Butt, et al.
Published: (2012-08-01)

Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
by: Priscilla C Hsu, et al.
Published: (2008-01-01)

Seroprevalences of Hepatitis B Virus and Hepatitis C Virus among Participants of an Asian Health Fair in the Lower Mainland, British Columbia
by: Stephen Ip, et al.
Published: (2015-01-01)

Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon
by: Jane D Collier, et al.
Published: (2000-01-01)

Burden of Disease and Cost of Chronic Hepatitis C Virus Infection in Canada
by: Robert P Myers, et al.
Published: (2014-01-01)

The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet—Remaining Challenges in Hepatitis C
by: Nicholas van Buuren, et al.
Published: (2016-01-01)

Prevalence and Incidence of Hepatitis C Virus in Hemodialysis Patients in British Columbia: Follow-up after a Possible Breach in Hemodialysis Machines
by: Andrew W Tu, et al.
Published: (2009-01-01)

Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians
by: Curtis L Cooper, et al.
Published: (2008-01-01)

Expanding access to healthcare for people who use drugs and sex workers: hepatitis C elimination implications from a qualitative study of healthcare experiences in British Columbia, Canada
by: Nance E. Cunningham, et al.
Published: (2024-04-01)

Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?
by: Kevork M. Peltekian, Dr., et al.
Published: (2011-07-01)

Parvovirus B19 in an Immunocompetent Adult Patient with Acute Liver Failure: An Underdiagnosed Cause of Acute Non-A-E Viral Hepatitis
by: J Kee Ho, et al.
Published: (2005-01-01)

Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan
by: Selena M. Sagan, et al.
Published: (2016-01-01)

Differential spatial distribution of hepatitis B virus by ethnicity in British Columbia, Canada: Expanded role of a large administrative cohort
by: Zahid Butt, et al.
Published: (2018-09-01)

Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.
by: Naveed Zafar Janjua, et al.
Published: (2016-01-01)

Impact of the COVID-19 Pandemic on Hepatitis C Treatment Initiation in British Columbia, Canada: An Interrupted Time Series Study
by: Richard L. Morrow, et al.
Published: (2024-04-01)

Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.
by: Jason Grebely, et al.
Published: (2014-01-01)

Missed Opportunities for Prevention of Perinatal Transmission of Hepatitis B: A Retrospective Cohort Study
by: Julie van Schalkwyk, et al.
Published: (2014-01-01)

Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohort
by: Maryam Darvishian, et al.
Published: (2022-10-01)

Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study
by: Jean Damascene Makuza, et al.
Published: (2022-11-01)

Diagnosis of Helicobacter pylori infection: serology vs. urea breath test
by: Miguel Imperial, et al.
Published: (2024-11-01)

The Second Canadian Symposium on Hepatitis C Virus: A Call to Action
by: Jason Grebely, et al.
Published: (2013-01-01)

The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
by: Sonya A MacParland, et al.
Published: (2014-01-01)

Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis.
by: Carole Lunny, et al.
Published: (2015-01-01)

Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy
by: Eric M Yoshida, et al.
Published: (2009-01-01)

Acute Hepatitis after Ingestion of a Preparation of Chinese Skullcap and Black Catechu for Joint Pain
by: Charilaos Papafragkakis, et al.
Published: (2016-01-01)

Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada
by: Kamila Romanowski, et al.
Published: (2017-09-01)

Association of hepatitis B virus treatment with all-cause and liver-related mortality among individuals with HBV and cirrhosis: a population-based cohort studyResearch in context
by: Jean Damascene Makuza, et al.
Published: (2024-08-01)

Successful Stem Cell Transplantation in a Patient with Pretransplant Hepatic Inflammatory Pseudotumour
by: Sanjay de Mel, et al.
Published: (2016-01-01)

Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
by: Viviane D Lima, et al.
Published: (2015-01-01)

COVID-19 Vaccine Effectiveness Among Patients With Maintenance Dialysis; Observations From Population Level Cohort Studies in 2 Large Canadian Provinces
by: Mohammad Atiquzzaman, et al.
Published: (2023-06-01)

Acute Liver Injury Associated with Khat Use in a 24-Year-Old Male
by: Mara Waters, et al.
Published: (2018-01-01)

Cystic Echinococcosis: Late Rupture and Complication of a Stable Pulmonary Cyst
by: J Fisher, et al.
Published: (2011-01-01)

Enterically Transmitted Viral Hepatitis: Hepatitis A and Hepatitis E
by: Phunchai Charatcharoenwitthaya
Published: (2020-07-01)

Hepatic Regeneration in Fulminant Hepatic Failure
by: Gerald Y Minuk
Published: (1993-01-01)

Hepatic Peliosis with Extra-Hepatic Manifestations
by: Asma Qureshi, et al.
Published: (2021-08-01)